Please select the option that best describes you:

What is your preferred dose to gross lymph nodes when treating non-metastatic high-risk prostate cancer?   

NCCN, NRG contouring guidelines, and NRG-GU-009 all recommend treating non-metastatic high risk prostate cancer with dose escalation to involved gross nodes to as high as the prostate dose if OAR constraints are met.



Answer from: Radiation Oncologist at Academic Institution
Comments
Radiation Oncologist at Minneapolis Radiation Oncology
Curious what OAR constraints you use specifically....
Radiation Oncologist at UC San Diego
True, I'm not sure there is definitive data to tel...
Radiation Oncologist at Kansas City VA Medical Center
I generally do SBRT to PET positive nodes, wheneve...
Sign in or Register to read more

Answer from: Radiation Oncologist at Academic Institution
Sign in or Register to read more

Answer from: Radiation Oncologist at Academic Institution
Sign in or Register to read more

Answer from: Radiation Oncologist at Community Practice
Sign in or Register to read more

Answer from: Radiation Oncologist at Academic Institution
Sign in or Register to read more

Answer from: Radiation Oncologist at Academic Institution
Sign in or Register to read more

Answer from: Radiation Oncologist at Community Practice
Comments
Radiation Oncologist at Mon Health
I have had excellent results with 60 Gray in 25 fr...
Sign in or Register to read more